Dr. Jeffrey R. Jay, M.D. »

Kyverna Therapeutics shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.7M 499k 7.50
2024-03-31 $3.7M 150k 24.84

More positions owned by Dr. Jeffrey R. Jay, M.D.

Urogen Pharma (URGN)
Neurogene (NGNE)
Abivax Sa Sponsored Ads (ABVX)
Merus N V (MRUS)
Pliant Therapeutics (PLRX)
Arcellx Common Stock (ACLX)
Dynavax Technologies Corp Com New (DVAX)
Evolus (EOLS)
Cytokinetics Com New (CYTK)
Dianthus Therapeutics (DNTH)
Insmed Com Par $.01 (INSM)
Zura Bio Class A Ord Shs (ZURA)
Kalvista Pharmaceuticals (KALV)
Ionis Pharmaceuticals (IONS)
Context Therapeutics (CNTX)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Bain Capital Life Sciences Investors
Northpond Ventures
Jpmorgan Chase & Co
Deerfield Management Company
Novo A/S
BlackRock
Vanguard Group
Millennium Management
Insight Holdings
Franklin Resources
T. Rowe Price Associates
Casdin Capital
Dr. Jeffrey R. Jay, M.D.
EcoR1 Capital

View all funds holding Kyverna Therapeutics